EU Drug Regulators Say AstraZeneca Vaccine Benefits Outweigh Risks

The EMA said that the benefits of the AstraZeneca vaccine still outweigh any potential risk of blood clot formation. This story appeared first on GreekReporter.com.

READ THE ORIGINAL POST AT greekreporter.com